Evidence map›Paper›PMID 42797719›Full record

ArticleToxics2026

Comparative Analysis of Test Methods for Predicting Dermal Sensitization Potency in Essential Oils: A Component-Based Prediction Model, GARDskin Dose-Response Assay, and Local Lymph Node Assay.

Joseph T Dawson, Tim Lindberg, Prabodh Satyal, Ambika Poudel, Dakota T Carter, Sara A Shah, Cécile Bascoul

Abstract read
In one paragraph

Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joseph T DawsondōTERRA International, Pleasant Grove, UT 84062, USA.ORCID 0009-0007-1317-0438
Tim LindbergSenzagen AB, 22381 Lund, Sweden.
Prabodh SatyaldōTERRA International, Pleasant Grove, UT 84062, USA.ORCID 0000-0002-2950-1074
Ambika PoudeldōTERRA International, Pleasant Grove, UT 84062, USA.
Dakota T CarterdōTERRA International, Pleasant Grove, UT 84062, USA.ORCID 0009-0006-3750-3412
Sara A ShahdōTERRA International, Pleasant Grove, UT 84062, USA.
Cécile BascouldōTERRA International, Pleasant Grove, UT 84062, USA.

Funding

doTERRA International n/a
6 · The paper itself

Abstract

The dose-response adaptation of the genomic allergen rapid detection for skin sensitizers (GARDskin DR) assay is a non-animal method for predicting sensitization potency. This proof-of-concept comparative analysis evaluates outputs from a component-based prediction model (CP), GARDskin DR, and historical local lymph node assays (LLNA), exploring the applicability of CP and GARDskin DR for evaluating the no-expected-sensitization induction level (NESIL) potencies of essential oils. Eight well-studied essential oils were selected: cedarwood, cinnamon bark, clove bud, geranium, lavender, lemongrass, spearmint, and tea tree oils. Each underwent GARDskin DR as well as GC-MS, from which CP model outputs were derived. GARDskin DR, CP, and LLNA outputs were compared graphically and using preliminary descriptive statistics. Results show overall statistical concordance in material ranking between methods (Kendall's W = 0.857,

Indexed as

comparative analysiscomponent-based predictionessential oilsGARDskin dose–responselocal lymph node assaymixturesnew approach methodologies (NAMs)non-animal methodsrisk assessmentskin sensitization

Identifiers

PMID42797719
PMCPMC13611667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.